SCHEMBL4477339

SCHEMBL4477339

CN=C1CCOCCN1c1ccc(NC(=O)C2(NC(=O)c3ccc(Br)s3)CCC2)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 2/20 0.51
RAB9A P51151 9/20 0.40
NPC1 O15118 8/20 0.40
SMN1; SMN2 Q16637 8/20 0.40
MAPT P10636 6/20 0.40
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
HTT P42858 5/20 0.40
LMNA P02545 4/20 0.40
ALDH1A1 P00352 4/20 0.40
HPGD P15428 3/20 0.40
TP53 P04637 2/20 0.40
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
CTSS P25774 1/20 0.40
MAPK1 P28482 2/20 0.37
NFKB1 P19838 2/20 0.36
NFKB2 Q00653 2/20 0.36
RELA Q04206 2/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4467392 0.98 F10 (0.51) F10RAB9ANPC1SMN1; SMN2MAPT
SCHEMBL4459654 0.93 F10 (0.52) F10RAB9ANPC1SMN1; SMN2MAPT
SCHEMBL4460990 0.92 F10 (0.50) F10RAB9ANPC1SMN1; SMN2MAPT
SCHEMBL4456140 0.92 F10 (0.51) F10RAB9ANPC1SMN1; SMN2MAPT
SCHEMBL4465293 0.91 F10 (0.49) F10RAB9ANPC1SMN1; SMN2MAPT
SCHEMBL4558783 0.90 F10 (0.48) F10RAB9ANPC1SMN1; SMN2MAPT
SCHEMBL4465226 0.89 F10 (0.58) F10RAB9ANPC1SMN1; SMN2MAPT
SCHEMBL4558995 0.89 F10 (0.48) F10RAB9ANPC1SMN1; SMN2MAPT
SCHEMBL5506296 0.88 TRPV1 (0.42) F10RAB9ANPC1SMN1; SMN2MAPT
SCHEMBL4468501 0.88 F10 (0.54) F10RAB9ANPC1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476663-B2 Substituted thiophene carboxamides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-01-13 US disclosed
US-20050277628-A1 Substituted thiophene carboxamides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277628-A1 Substituted thiophene carboxamides OTC, SLC22A8, DDC F10 2132/4885RAB9A 1694/4885NPC1 2769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.